MTTI and Monrol Have Signed a Clinical Supply Agreement for Lu-177 n.c.a.
Business Wire India Eczacıbaşı-Monrol Nuclear Products Co. (Monrol) today announced their agreement with Molecular Targeting Technologies, Inc. (MTTI), a clinical stage biotech company focused on developing innovative therapies for rare…